» Articles » PMID: 40008002

Case Report: Unraveling a Unique Case of Male Occult Breast Cancer with Axillary Intricacies and a Comprehensive Literature Dive

Overview
Journal Front Oncol
Specialty Oncology
Date 2025 Feb 26
PMID 40008002
Authors
Affiliations
Soon will be listed here.
Abstract

Male breast cancer is a rare neoplasm, accounting for approximately 1% of all breast cancer cases. It typically presents as a painless, retroareolar mass. An exceedingly rare variant is male occult breast cancer, which is primarily characterized by axillary lymph node enlargement without an identifiable primary breast tumor. We report an intriguing case of a septuagenarian patient diagnosed with male occult breast cancer. The patient presented with both axillary lymph node enlargement and an associated axillary skin ulcer, and was subsequently diagnosed with male occult breast cancer with metastases to the axillary and clavicular lymph nodes, as well as more distant sites. His treatment involved a multidisciplinary approach, including HER2-targeted therapy, chemotherapy, axillary lymph node dissection, and radiotherapy. Regular follow-ups have shown that his condition remains stable. Notably, this is the first documented case of male occult breast cancer with distant metastasis that was successfully treated with surgery and radiotherapy following systemic therapy. This case highlights the complex clinical presentation and management of male occult breast cancer. Our findings suggest that surgical intervention may be a feasible option post-downstaging by systemic therapy, even in the presence of distant metastases.

References
1.
Khandelwal A, Garguilo G . Therapeutic options for occult breast cancer: a survey of the American Society of Breast Surgeons and review of the literature. Am J Surg. 2005; 190(4):609-13. DOI: 10.1016/j.amjsurg.2005.06.026. View

2.
Ellerbroek N, Holmes F, Singletary E, Evans H, Oswald M, McNeese M . Treatment of patients with isolated axillary nodal metastases from an occult primary carcinoma consistent with breast origin. Cancer. 1990; 66(7):1461-7. DOI: 10.1002/1097-0142(19901001)66:7<1461::aid-cncr2820660704>3.0.co;2-z. View

3.
Soran A, Ozmen V, Ozbas S, Karanlik H, Muslumanoglu M, Igci A . Primary Surgery with Systemic Therapy in Patients with de Novo Stage IV Breast Cancer: 10-year Follow-up; Protocol MF07-01 Randomized Clinical Trial. J Am Coll Surg. 2021; 233(6):742-751.e5. DOI: 10.1016/j.jamcollsurg.2021.08.686. View

4.
Giordano S . Breast Cancer in Men. N Engl J Med. 2018; 378(24):2311-2320. DOI: 10.1056/NEJMra1707939. View

5.
Vlastos G, Jean M, Mirza A, Mirza N, Kuerer H, Ames F . Feasibility of breast preservation in the treatment of occult primary carcinoma presenting with axillary metastases. Ann Surg Oncol. 2001; 8(5):425-31. DOI: 10.1007/s10434-001-0425-6. View